UB Paderborn / Katalog / Suche / in CDI

Short-term effects of atorvastatin on C-reactive protein

European heart journal, 2002-05, Vol.23 (10), p.794-799

2002

Volltextzugriff (PDF)

Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.1137-1144

2011

Volltextzugriff (PDF)

Hypertriglyceridemia as a possible risk factor for prostate cancer

Prostate cancer and prostatic diseases, 2005-12, Vol.8 (4), p.316-320

2005

Volltextzugriff (PDF)

Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer

Journal of oncology pharmacy practice, 2011-09, Vol.17 (3), p.292-294

2011

Volltextzugriff (PDF)

Effect of thyroid function on concentrations of lipoprotein(a)

Clinical chemistry (Baltimore, Md.), 1993-12, Vol.39 (12), p.2466

1993

Volltextzugriff (PDF)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

European heart journal, 2020, Vol.41 (1), p.111

2020

Volltextzugriff (PDF)

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus

The Journal of clinical investigation, 1992-12, Vol.90 (6), p.2234-2241

1992

Volltextzugriff (PDF)

Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study

Clinica chimica acta, 1999-11, Vol.289 (1), p.159-172

1999

Volltextzugriff (PDF)

Comparison of Bezafibrate and Simvastatin in the Treatment of Dyslipidaemia in Patients with NIDDM

Diabetic medicine, 1997-07, Vol.14 (7), p.564-570

1997

Volltextzugriff (PDF)

Comparability of Serum and Plasma Concentrations of Haemostasis Activation Markers

Clinical chemistry and laboratory medicine, 2001-07, Vol.39 (7), p.627-630

2001

Volltextzugriff (PDF)

Improvement of lipid profile in Type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I

Diabetologia, 1993-05, Vol.36 (5), p.465-469

1993

Volltextzugriff (PDF)

Effect of Thyroid Hormones on Lp(a) and Lipid Metabolism

Clinical chemistry and laboratory medicine, 1998-09, Vol.36 (9), p.731-735

1998

Volltextzugriff (PDF)

Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies

Clinica chimica acta, 1994-03, Vol.225 (2), p.123-136

1994

Volltextzugriff (PDF)

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A

European journal of endocrinology, 1994-09, Vol.131 (3), p.251

1994

Volltextzugriff (PDF)

Diagnostic and Prognostic Value of Biochemical Markers in Malignant Bone Disease: A Prospective Study on the Effect of Bisphosphonate on Pain Intensity and Progression of Malignant Bone Disease

Clinical chemistry and laboratory medicine, 1998-11, Vol.36 (11), p.879-885

1998

Volltextzugriff (PDF)

High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean)

Arteriosclerosis and thrombosis, 1991-11, Vol.11 (6), p.1730

1991

Volltextzugriff (PDF)

Human Plasma Lipoproteins

1, 2019

Volltextzugriff (PDF)

Comment from the lipidologic viewpoint

Praxis (Bern. 1994), 2009-02, Vol.98 (3), p.125

Riesen, W F

2009

Volltextzugriff (PDF)

Increased Lipoprotein(a) levels are not a steady prothrombotic defect

Blood, 2001-09, Vol.98 (6), p.1993-1994

2001

Volltextzugriff (PDF)

Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults

Nephrology, dialysis, transplantation, 2007-04, Vol.22 (4), p.1107-1114

2007

Volltextzugriff (PDF)

Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens

Clinical chemistry (Baltimore, Md.), 1993-02, Vol.39 (2), p.271

1993

Volltextzugriff (PDF)

Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia

European journal of clinical pharmacology, 1989, Vol.37 (2), p.199-203

1989

Volltextzugriff (PDF)

Effects of long-term, self-monitored exercise on the serum lipoprotein and apolipoprotein profile in middle-aged men

Atherosclerosis, 1990-02, Vol.81 (1), p.19-31

1990

Volltextzugriff (PDF)

Elevation of the serum total and free prostate-specific antigen levels after stent implantation in patient with coronary artery disease

Swiss medical weekly, 2009-11, Vol.139 (45-46), p.646

Riesen, W F

2009

Volltextzugriff (PDF)

Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II

European journal of clinical pharmacology, 1990-08, Vol.39 (2), p.101-105

1990

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Short-term effects of atorvastatin on C-reactive protein

Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates

Hypertriglyceridemia as a possible risk factor for prostate cancer

Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer

Effect of thyroid function on concentrations of lipoprotein(a)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus

Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study

Comparison of Bezafibrate and Simvastatin in the Treatment of Dyslipidaemia in Patients with NIDDM

Comparability of Serum and Plasma Concentrations of Haemostasis Activation Markers

Improvement of lipid profile in Type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I

Effect of Thyroid Hormones on Lp(a) and Lipid Metabolism

Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A

Diagnostic and Prognostic Value of Biochemical Markers in Malignant Bone Disease: A Prospective Study on the Effect of Bisphosphonate on Pain Intensity and Progression of Malignant Bone Disease

High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean)

Human Plasma Lipoproteins

Comment from the lipidologic viewpoint

Increased Lipoprotein(a) levels are not a steady prothrombotic defect

Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults

Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens

Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia

Effects of long-term, self-monitored exercise on the serum lipoprotein and apolipoprotein profile in middle-aged men

Elevation of the serum total and free prostate-specific antigen levels after stent implantation in patient with coronary artery disease

Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II

Suchergebnisse filtern